Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Brain Metastases
Lymphopenia used to prognosticate survival after whole brain radiotherapy for brain metastases
January 5th, 2006
Lymphopenia could be used to prognosticate patient survival after whole brain radiotherapy (WBR) for brain metastases (BM) from breast carcinoma. "To determine overall survival (OS) and independent prognostic factors inpatients with BM from breast cancer treated by WBR. One hundred and twenty (120) women with BM, treated in a single French cancer center between 02/91 and 06/01, were reviewed," investigators in France reported. "BM were confirmed by computed tomography or magnetic resonance imaging. Survival time was defined as the time interval from the date of BM to the date of death or last follow-up. A Cox proportional hazards regression model was...
Source: Women's Health Weekly (2006-01-05)
|
